Name: FERMENTA BIOTECH LIMITED Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 671 across all filing types

Latest filing 2023-06-01 Earnings Release

Country IN India

Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing	Released	Lang
Further to our intimation dated May 29, 2023 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ended .... Earnings Release Q4 2023	2023-06-01	English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation with our intimation given vide our letter dated May 29, 2023, .... Regulatory Filings	2023-05-30	English
Pursuant to the provisions of Regulation 24A of the Listing Regulations read with SEBI circular CIR/CFD/CMD1/27/2019 dated February 8, 2019, we are enclosing herewith the annual secretarial .... Regulatory Filings	2023-05-30	English
In connection with our earlier intimation dated May 29, 2023 regarding the Outcome of the Board Meeting for approval of the Audited Financial Results (Standalone and Consolidated) for the .... Regulatory Filings	2023-05-29	English
We write to inform you that the Board of Directors of the Company at its meeting held on May 29, 2023 has, inter alia: 1. Approved the Audited Financial Results (Standalone and Consolidated) .... Regulatory Filings	2023-05-29	English
We write to inform you that the Board of Directors of the Company at its meeting held on May 29, 2023 has, inter alia: 1. Approved the Audited Financial Results (Standalone and Consolidated) .... Regulatory Filings	2023-05-29	English

Browse filings by year

8 years

	ID	Filing	Released	Lang
2023 15 filings
	45995141	Further to our intimation dated May 29, 2023 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ended .... Earnings Release Q4 2023	2023-06-01	English
	45995147	Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation with our intimation given vide our letter dated May 29, 2023, .... Regulatory Filings	2023-05-30	English
	45995159	Pursuant to the provisions of Regulation 24A of the Listing Regulations read with SEBI circular CIR/CFD/CMD1/27/2019 dated February 8, 2019, we are enclosing herewith the annual secretarial .... Regulatory Filings	2023-05-30	English
	45995152	In connection with our earlier intimation dated May 29, 2023 regarding the Outcome of the Board Meeting for approval of the Audited Financial Results (Standalone and Consolidated) for the .... Regulatory Filings	2023-05-29	English
	45995242	We write to inform you that the Board of Directors of the Company at its meeting held on May 29, 2023 has, inter alia: 1. Approved the Audited Financial Results (Standalone and Consolidated) .... Regulatory Filings	2023-05-29	English
	45995246	We write to inform you that the Board of Directors of the Company at its meeting held on May 29, 2023 has, inter alia: 1. Approved the Audited Financial Results (Standalone and Consolidated) .... Regulatory Filings	2023-05-29	English
	45995231	Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises .... Capital/Financing Update	2023-05-25	English
	45995236	In continuation to our letter dated May 22, 2023, we wish to inform you that the Company has filed the certified copy of order passed by the National Company Law Tribunal, Mumbai Bench .... Regulatory Filings	2023-05-24	English
	45995262	The Board of Directors of the Company, inter alia, considered and noted the certified copy of the order passed by the National Company Law Tribunal, Mumbai Bench ('NCLT') dated May 08, .... Regulatory Filings	2023-05-22	English
	45995254	Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 .... Regulatory Filings	2023-05-22	English
	45995250	Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about .... Regulatory Filings	2023-05-18	English
	45995257	Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises .... Capital/Financing Update	2023-05-17	English
	45995269	Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises .... Regulatory Filings	2023-05-15	English
	45995265	With reference to the captioned subject, we would like to inform you that the National Company Law Tribunal, Mumbai Bench ('NCLT') has approved the Composite Scheme of Amalgamation and .... M&A Activity	2023-05-09	English
	45995274	Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2023-04-30	English

Page 18 of 45

Prev … 16 17 18 19 20 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

FERMENTA BIOTECH LIMITED via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID60716

TickerFERMENTA

ISININE225B01021

Endpoints

most-used routes for this company

GET	/api/companies/60716/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=60716	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=60716	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for FERMENTA BIOTECH LIMITED

$ curl https://api.financialreports.eu/api/filings/?company=60716 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 60716},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for FERMENTA BIOTECH LIMITED (id: 60716)"

FERMENTA BIOTECH LIMITED — Investor Relations & Filings